Literature DB >> 19779197

Chloroquine transport via the malaria parasite's chloroquine resistance transporter.

Rowena E Martin1, Rosa V Marchetti, Anna I Cowan, Susan M Howitt, Stefan Bröer, Kiaran Kirk.   

Abstract

The emergence and spread of chloroquine-resistant Plasmodium falciparum malaria parasites has been a disaster for world health. Resistance is conferred by mutations in the Chloroquine Resistance Transporter (PfCRT), an integral membrane protein localized to the parasite's internal digestive vacuole. These mutations result in a marked reduction in the accumulation of chloroquine (CQ) by the parasite. However, the mechanism by which this occurs is unclear. We expressed both wild-type and resistant forms of PfCRT at the surface of Xenopus laevis oocytes. The resistant form of PfCRT transported CQ, whereas the wild-type protein did not. CQ transport via the mutant PfCRT was inhibited by CQ analogs and by the resistance-reverser verapamil. Thus, CQ resistance is due to direct transport of the drug via mutant PfCRT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779197     DOI: 10.1126/science.1175667

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  124 in total

1.  Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine.

Authors:  Fabian Müller; Jörg König; Hartmut Glaeser; Ingrid Schmidt; Oliver Zolk; Martin F Fromm; Renke Maas
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Glutathione.

Authors:  Graham Noctor; Guillaume Queval; Amna Mhamdi; Sejir Chaouch; Christine H Foyer
Journal:  Arabidopsis Book       Date:  2011-02-18

3.  Degrees of chloroquine resistance in Plasmodium - is the redox system involved?

Authors:  Adele M Lehane; Christopher A McDevitt; Kiaran Kirk; David A Fidock
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-12-01       Impact factor: 4.077

Review 4.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

5.  Differential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparum strains expressing the same isoform of mutant PfCRT.

Authors:  Adele M Lehane; Donelly A van Schalkwyk; Stephanie G Valderramos; David A Fidock; Kiaran Kirk
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

Review 6.  Malaria biology and disease pathogenesis: insights for new treatments.

Authors:  Louis H Miller; Hans C Ackerman; Xin-zhuan Su; Thomas E Wellems
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

Review 7.  Malarial hemozoin: from target to tool.

Authors:  Lorena M Coronado; Christopher T Nadovich; Carmenza Spadafora
Journal:  Biochim Biophys Acta       Date:  2014-02-17

8.  Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum.

Authors:  Stephanie G Valderramos; Juan-Carlos Valderramos; Lise Musset; Lisa A Purcell; Odile Mercereau-Puijalon; Eric Legrand; David A Fidock
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

9.  Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression.

Authors:  Maria Isabel Veiga; Pedro Eduardo Ferreira; Berit Aydin Schmidt; Ulf Ribacke; Anders Björkman; Ales Tichopad; José Pedro Gil
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

10.  Experimental evolution, genetic analysis and genome re-sequencing reveal the mutation conferring artemisinin resistance in an isogenic lineage of malaria parasites.

Authors:  Paul Hunt; Axel Martinelli; Katarzyna Modrzynska; Sofia Borges; Alison Creasey; Louise Rodrigues; Dario Beraldi; Laurence Loewe; Richard Fawcett; Sujai Kumar; Marian Thomson; Urmi Trivedi; Thomas D Otto; Arnab Pain; Mark Blaxter; Pedro Cravo
Journal:  BMC Genomics       Date:  2010-09-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.